OMADA HEALTH INC (OMDA) Fundamental Analysis & Valuation

NASDAQ:OMDA • US68170A1088

Current stock price

14.62 USD
-0.18 (-1.22%)
At close:
14.62 USD
0 (0%)
After Hours:

This OMDA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. OMDA Profitability Analysis

1.1 Basic Checks

  • In the past year OMDA has reported negative net income.
OMDA Yearly Net Income VS EBIT VS OCF VS FCFOMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -22.64%, OMDA is doing worse than 82.18% of the companies in the same industry.
  • The Return On Equity of OMDA (-29.94%) is worse than 68.32% of its industry peers.
Industry RankSector Rank
ROA -22.64%
ROE -29.94%
ROIC N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMDA Yearly ROA, ROE, ROICOMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60

1.3 Margins

  • With an excellent Gross Margin value of 62.16%, OMDA belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for OMDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OMDA Yearly Profit, Operating, Gross MarginsOMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. OMDA Health Analysis

2.1 Basic Checks

  • OMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OMDA remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, OMDA has a worse debt to assets ratio.
OMDA Yearly Shares OutstandingOMDA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
OMDA Yearly Total Debt VS Total AssetsOMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • OMDA has an Altman-Z score of 6.41. This indicates that OMDA is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of OMDA (6.41) is better than 93.07% of its industry peers.
  • There is no outstanding debt for OMDA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.41
ROIC/WACCN/A
WACC8.92%
OMDA Yearly LT Debt VS Equity VS FCFOMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • OMDA has a Current Ratio of 3.64. This indicates that OMDA is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.64, OMDA belongs to the best of the industry, outperforming 87.13% of the companies in the same industry.
  • A Quick Ratio of 3.59 indicates that OMDA has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.59, OMDA belongs to the best of the industry, outperforming 88.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.59
OMDA Yearly Current Assets VS Current LiabilitesOMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. OMDA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.18% over the past year.
  • OMDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.29%.
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • OMDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.58% yearly.
  • Based on estimates for the next years, OMDA will show a very strong growth in Revenue. The Revenue will grow by 29.61% on average per year.
EPS Next Y69.17%
EPS Next 2Y38.65%
EPS Next 3Y31.07%
EPS Next 5Y26.58%
Revenue Next Year52.49%
Revenue Next 2Y36.77%
Revenue Next 3Y30.85%
Revenue Next 5Y29.61%

3.3 Evolution

OMDA Yearly Revenue VS EstimatesOMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OMDA Yearly EPS VS EstimatesOMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. OMDA Valuation Analysis

4.1 Price/Earnings Ratio

  • OMDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OMDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OMDA Price Earnings VS Forward Price EarningsOMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OMDA Per share dataOMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • OMDA's earnings are expected to grow with 31.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.65%
EPS Next 3Y31.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OMDA Dividend Analysis

5.1 Amount

  • OMDA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OMDA Fundamentals: All Metrics, Ratios and Statistics

OMADA HEALTH INC

NASDAQ:OMDA (3/17/2026, 8:00:02 PM)

After market: 14.62 0 (0%)

14.62

-0.18 (-1.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-05
Earnings (Next)N/A
Inst Owners65.48%
Inst Owner Change37%
Ins Owners6.23%
Ins Owner Change18.34%
Market Cap846.64M
Revenue(TTM)354.16M
Net Income(TTM)-65.07M
Analysts78.82
Price Target27.08 (85.23%)
Short Float %7.82%
Short Ratio2.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.37%
Min EPS beat(2)5.88%
Max EPS beat(2)22.85%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.17%
Min Revenue beat(2)9.04%
Max Revenue beat(2)9.3%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.79%
EPS NY rev (1m)0%
EPS NY rev (3m)15.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.39
P/FCF N/A
P/OCF N/A
P/B 3.9
P/tB 4.21
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.12
BVpS3.75
TBVpS3.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.64%
ROE -29.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.16%
FCFM N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.64
Quick Ratio 3.59
Altman-Z 6.41
F-ScoreN/A
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)69.64%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y69.17%
EPS Next 2Y38.65%
EPS Next 3Y31.07%
EPS Next 5Y26.58%
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year52.49%
Revenue Next 2Y36.77%
Revenue Next 3Y30.85%
Revenue Next 5Y29.61%
EBIT growth 1Y33.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.04%
EBIT Next 3Y33.24%
EBIT Next 5Y27.95%
FCF growth 1Y27.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.28%
OCF growth 3YN/A
OCF growth 5YN/A

OMADA HEALTH INC / OMDA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OMADA HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to OMDA.


Can you provide the valuation status for OMADA HEALTH INC?

ChartMill assigns a valuation rating of 1 / 10 to OMADA HEALTH INC (OMDA). This can be considered as Overvalued.


Can you provide the profitability details for OMADA HEALTH INC?

OMADA HEALTH INC (OMDA) has a profitability rating of 1 / 10.


What is the expected EPS growth for OMADA HEALTH INC (OMDA) stock?

The Earnings per Share (EPS) of OMADA HEALTH INC (OMDA) is expected to grow by 69.17% in the next year.